• Find people
• Intranet

Infectious Pathology and Antimicrobials Juan Pablo Horcajada

Publications 2025 (9)

• Montero MM^*, Domene-Ochoa S, Prim N, López Causapé C, Echeverría-Esnal D, Sorli L, Luque S, Padilla E, Grau S, Oliver A, Horcajada JP^*. Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK/PD model. Int J Antimicrob Ag 2025; 65: (en Premsa).
• González-Guerrero A, Navarrete ME, Benaiges D, Steinhauer EG, Marcos-Garcia L, Oliveras A, Recasens L, Pedro-Botet Montoya J^*. Efficacy and safety of PCSK9 inhibitors in real life. Clin Invest Arterioscl 2025: (en Premsa).
• Montero MM^*, Domene-Ochoa S, Prim N, Ferola EB, López Causapé C, Gomis-Font MA, Morisaki MFA, Echeverría-Esnal D, Sorli L, Luque S, Padilla E, Grau S, Oliver-Palomo A, Horcajada JP^*. Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy. Eur J Clin Microbiol Infect Dis 2025: (en Premsa).
• Garnacho-Montero J, Aguado JM, Alemparte E, Horcajada JP, López-Medrano F, Ramírez P, Giró-Perafita A^*, Blasco M, Suberviola B. Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals. Rev Esp Quimioter 2025; 38(3): 197-207.
• de Antonio-Cuscó M, Sorli L^*, Muñoz-Bermúdez R, López-Mula C, Parrilla FJ, Gracia-Arnillas MP, Prim N, Campillo N, Horcajada JP, Masclans JR, Grau S, Luque S. Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study. J Antimicrob Chemother 2025; 80(2): 554-562.
• Colominas-González E, de Antonio-Cuscó M, Masip M, Martín-Conde MT, Cardona G, Fresán-Restituto D, Comas D, Roch MA, López B, Torres-Bondia FI, Retamero A, Knobel H, Luque S^*. Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy. Eur J Hosp Pharm Sci Pract 2025; 32(3): 266-271.
• Ovejero D, Ribes A, Villar-García J, Trenchs M, Lopez D, Nogués X, Güerri R, García-Giralt N^*. Balneotherapy for the treatment of post-COVID syndrome: a randomized controlled trial. BMC Complement Med Ther . 2025; 25(1): 37.
• Cuervo G^*, Hernández-Meneses M, de Alarcón A, Luque-Marquez R, Alonso-Socas MM, Lopez-Lirola A, González-Ramallo V, Goikoetxea AJ, Nicolás-Pérez D, Goenaga MA, Merino E, Escrihuela-Vidal F, Martín-Dávila P, Loeches B, Boix Palop L, Gasch O, Campreciós M, Hernández-Torres A, García-Álvarez L, Pajarón M, Ribas MA, Blanes-Hernández R, Lopez Montesinos I, Lopez LE, Vidal B, Fernández-Pittol M, Navarro D, Moreno A, Sala C, Ambrosioni J^*, Miró JM, OraPAT-IE GAMES Investigators. Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial. Infect Dis Ther . 2025; 14(3): 643-655.
• Sánchez-Montalvá A^*, Caminero JA, Guna MR, Sanz TR, Rabuñal R, Millet JP, Gullón-blanco JA, Anibarro L, Perez-mendoza G, Medina JF, González-galán V, Tabernero E, Annex. Members of the Spanish MDR TB consortium group (...,Sánchez F,...). Executive summary: Clinical practice guidelines on the management of resistant tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enferm Infecc Microbiol Clin 2025; 42(10): 588-596.